Our results are in favor of PSA screening as QCI had increased whenever policies were in favor of screening and decreased when screenings were limited, although PSA testing could lead to overdiagnosis and overtreatment, and consequently, therapy complications such as incontinence and erectile dysfunction. The gene discussed is KLK3; the disease is Urinary incontinence.